Role of tofacitinib in chronic plaque psoriasis
Phase 3
Not yet recruiting
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2024/07/069964
- Lead Sponsor
- Dr Rohit Kumar Singh
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.patients of 18 to 65 years of age
2.BSA more than 5% and PASI more than 3
3.Patients with well controlled diabetes, hypertension and thyroid disorder
Exclusion Criteria
1.Patients not consenting to the study.
2.Patient with deranged biochemical profile.
3.Pregnant and lactating women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method